Poll Shows Strong, Bipartisan Support For Bill Expanding Access To Cancer Care

WASHINGTON, D.C. — The Coalition to Improve Access to Cancer Care today unveiled polling data that demonstrates broad, bipartisan support for the Cancer Drug Parity Act, legislation pending before Congress that would end the cost disparity for certain cancer treatments based solely on how insurers classify that medicine. H.R. 1409, co-sponsored by Representative Leonard Lance (R-NJ-07) and Representative Brian Higgins (D-NY-26) ensures that any health plan covering cancer care offer patients the same level of cost-sharing for all forms of cancer medicine.

“Bipartisan support for the Cancer Drug Parity Act has grown to 136 cosponsors, reflecting the strong momentum in Congress to pass this piece of meaningful cancer treatment legislation, said Congressman Lance. “Support from the public is surging as well, according to this important survey data released today.  It’s time for Congress to act.  Patients deserve for this disparity in coverage to end and to allow health care decisions to be based on the best information not outdated guidelines.”

Read full press release here.